Page 2,038«..1020..2,0372,0382,0392,040..2,0502,060..»

Miami Stem Cell Surgery | Molecular Orthopaedics | Florida …

Posted: August 23, 2014 at 9:58 am

Stem cell surgery may be the perfect treatment for those who are suffering from a bulging disc, continuous pain due to arthritis or other joint problems, those with a partially torn muscle, ligament or tendon as well as individuals who have chronic bursitis or avascular necrosis of the bone. The Institute of Regenerative and Molecular Orthopedics located in Boca Raton, Florida has now expanded their services throughout South Florida including the Miami area. Although stem cell surgical procedures are relatively new, Dr. Purita who heads this practice, and his staff, are well experienced at doing stem cell surgery, having literally done thousands of them.

Everyone has stem cells. Mesenchymal stem cells function to repair damaged tissue within the body. When injuries occur, the blood supply to the injury site can become impaired, preventing these necessary stem cells from reaching the damaged tissue, thus preventing proper healing. Because the injury site does not receive proper oxygen supply via blood, the body does not sense that there is an injury. Therefore healing cannot take place. By using stem cell surgery, the injury site receives the needed stem cells for proper healing. This is done by collecting bone marrow from the pelvic area of the patient using a small needle. Discomfort is minimal as anesthetic agents are used. The collected bone marrow is then placed in a spinning device that separates the stem cells from the bone marrow. Stem cells are then injected into the injury site, stimulating damaged cells to repair themselves.

Most patients who undergo stem cell orthopedic surgery experience significant improvements in their symptoms within 2 to 3 months, sometimes eliminating the need for surgery or long-term medication use. Full function of the treated body part often returns and pain is eliminated. This treatment can offer individuals who have been constantly suffering from orthopedic injuries or disorders to finally get the relief they deserve. Depending on the condition, repeated injections may be needed each month for about 3 to 6 months for full healing. For those who live in or around Miami, the Miami Stem Cell Surgery procedure may just be the answer you have been looking for.

More here:

Miami Stem Cell Surgery | Molecular Orthopaedics | Florida ...

Posted in Florida Stem Cells | Comments Off on Miami Stem Cell Surgery | Molecular Orthopaedics | Florida …

Bone Marrow Stem Cell Transplant For Myeloma, Hodgkins …

Posted: August 23, 2014 at 9:58 am

Welcome...

Every day, lives are changed as a result of the South Florida Bone Marrow/Stem Cell Transplant Institute ("The Institute").

Located at Bethesda Health City in Boynton Beach, Florida, the Institute offers a full range of outpatient treatments for many hematologic cancers including: Non-Hodgkins Lymphoma, Hodgkins Lymphoma, Leukemia, and Multiple Myeloma. There are also other treatments such as immunotherapy for cancers.

Under the direction of Dr. Dipnarine Maharaj, our patients are cared for by a team of highly-skilled professionals with extensive training and experience in treating cancers that react favorably to stem cell transplants. This specialized approach helps patients whose cancer has shown little or no response to other methods of treatment.

Characterized by a drive for excellence, the Institutes programs are dedicated to constantly improving the quality of care for our patients. Please take a moment to browse our website. If you would like more information on the institute or the bone marrow transplant procedure, please call561-752-5522.

Dr. Maharaj was awarded the April 2010 Physician of the month at Bethesda Memorial Hospital!

The South Florida Bone Marrow Stem Cell Transplant Institute is a accredited by the JOINT COMMISION ON ACCREDITATION OF HEALTH CARE ORGANIZATIONS (JCAHO).

Visit link:

Bone Marrow Stem Cell Transplant For Myeloma, Hodgkins ...

Posted in Florida Stem Cells | Comments Off on Bone Marrow Stem Cell Transplant For Myeloma, Hodgkins …

MD Stem Cells Announces First Eye Patient Treated With …

Posted: August 23, 2014 at 9:58 am

Fort Lauderdale, FL (PRWEB) November 14, 2012

MD Stem Cells reports the first treatment of an eye patient in Florida using the innovative stem cell injection technique they helped develop.

"We have helped a number of eye patients utilize Bone Marrow Derived Stem Cells or BMSC for retinal and optic nerve diseases and have observed macular degeneration, myopic degeneration, hereditary retinopathies, optic nerve and glaucoma patients, among others, have visual improvements following treatment. Our retinal surgeon has used both subretinal surgery and different injection techniques in the past for the placement of BMSC in ocular disease. We collaboratively developed a dual injection technique that we believe takes advantage of the recently identified active vascular expulsion mechanism of cell transmigration and are very excited about our ability to deliver the BMSC to the RPE, retina and optic nerve. Dr Levy mentioned that the new technique has already been used by the retinal surgeon for a number of patients in Europe and after careful preparation is now being performed in the United States.

It was a worthwhile effort to arrange for the board certified physicians and operating rooms for the new procedure to be performed in the United States. We are extremely pleased to see this high level of adult stem cell treatment come to Florida.

The Europeans have had extensive experience using BMSC in a number of different diseases and believe their effectiveness to be significantly superior to adipose derived stem cells. It is their preferred source of adult stem cells. Certainly patients with ophthalmology disease have been treated with BMSC successfully.

The new dual injection approach appears to be resulting in a faster and more vigorous response for the eye patients exclaimed Dr Levy. The retinal surgeon has been surprised regarding the tissue regrowth and rapidity of visual improvement in several patients.

With respect to BMSC, better outcomes may depend on how well the health and viability of the stem cells is maintained as well as the quality of the surgery in placing the cells. With the MD Stem Cell providers, the autologous BMSC come directly from the patient themselves, undergo minimal manipulation during the isolation process and never leave the operating room so they can be reinjected almost immediately.

This delicate approach, coupled with the precise dual placement our experienced retinal surgeon provides, may be the explanation for the results we are seeing. Most ophthalmology patients will have a stem cell procedure only once and it makes sense to choose an approach that will give the best opportunity for improvement, opined Dr Levy.

Dr Levy indicated this particular patient suffered from optic nerve disease and that other scheduled patients will include AMD or macular degeneration, myopic degeneration and other diseases of the retina and optic nerve that can be expected to potentially benefit. We believe strongly that regenerative medicine is evolving and will expand in many directions over the next few years. We are excited to help bring access to this advanced stem cell technology to the USA for ophthalmology.

MD Stem Cells is a practice management and development organization working closely with adult stem cell providers globally. Inquires may be made directly to stevenlevy(at)mdstemcells(dot)com or visit our website http://www.mdstemcells.com.

Read more here:

MD Stem Cells Announces First Eye Patient Treated With ...

Posted in Florida Stem Cells | Comments Off on MD Stem Cells Announces First Eye Patient Treated With …

Stem Cells Florida | Stem Cell Therapy in Miami Beach By …

Posted: August 23, 2014 at 9:58 am

A human foot & ankle is a strong, mechanical structure that contain 26 bones, 33 joints, and more than 100 muscles, tendons & ligaments.

The 52 bones in your feet make up one quarter of all the bones in your body. When they are out of alignment, so is the rest of your body.

There are approximately 250,000 sweat glands in a pair of feet, and they excrete as much as half a pint of moisture each day.

The soles of your feet contain more sweat glands and sensory nerve endings per square centimeter than any other part of the body.

The American Podiatry Medical Association says buying shoes is best done during the afternoon. Your feet tend to swell a little during the day, and its best to buy shoes that fit then.

Women are 4 times more likely to have foot problems than men are, mostly due to footwear.

A 2-inch high heel can increase the load on the forefoot by 75%.

Many people have one foot larger than the other, so its best to fit the larger one while standing.

The American Podiatric Medical Association states the average person takes 8,000 to 10,000 steps a day, which add up to 115,000 miles in a lifetime more than 4 times the circumference of the globe.

During an average day of walking, the total forces on your feet can total hundreds of tons, equivalent to an average of a fully loaded cement truck.

Follow this link:

Stem Cells Florida | Stem Cell Therapy in Miami Beach By ...

Posted in Florida Stem Cells | Comments Off on Stem Cells Florida | Stem Cell Therapy in Miami Beach By …

Stem Cell Companies – A Comprehensive Overview

Posted: August 23, 2014 at 9:58 am

Over the last decade, as research into the application of stem cell technology advanced a large array of stem cell companies has been formed. While there are identifiable focus areas for companies within this space, the purpose of these companies often vary greatly as businesses are trying to create niches within this lucrative industry. This site aims to help you understand the different types of stem cell companies that exist out there and the typical services they offer. Whether you are doing research for investment or medical purposes we hope to be able to help you navigate the maze of companies and relationships involved in stem cell technology and treatments.

Lets start by taking a look at some prominent players in the market:

Based in Boston USA, 3Dm stem cell company innovates treatments for regenerating tissues and healing wounds. Its product is PuraMatrix, an award winning therapy. They incorporate nanotechnology which , when injected into the body, releases stem cell proteins for the purposes of bone and heart regeneration. The treatment was in preclinical trials in 2007. The treatment in essence looks at the building blocks of the cell and engineers a solution to synthesising amino acids. In 2010 the stem cell company found itself among the top 100 with exceptional potential globally.

Aastrom in Michgan USA on the other hand, also treats heat disease with their product ixmyelocel-T. This innovation harnesses the bodys ability to heal itself and also treats critical limb ischemia (CLI). CLI is a vascular/arterial obstruction causing the flow of blood to extremities.

Their Ixmyelocel-T (see diagram) employs their own system for processing cells assisting to expand these organisms many times more than naturally present in a small sample of bone marrow.

Image courtesy of http://www.aastrom.com/

The product is designed to treat patients who suffer from not only CLI but also Dilated cardiomyopathy or DCM. This is a disease whereby the hearts ability to process blood becomes compromised which in turn affects the other organs. This focus falls on the heart muscle and ventricles, ailing men more often than women.

In treatment, stem cell companies such as Aastrom begin with extracting cells from the patient to ensure optimal immune integration. The bone marrow is activated on a cellular level to multiply to three hundred times the normal cell ratio. A variety of relevant cells are targeted and used in the treatment to assist with the immune system optimisation. The process is conducted in the least invasive manner possible for bone marrow transplants with duration of fifteen minutes for extraction and twenty for the outpatient procedure. Stem cell companies such as Aastrom offer the surety of a 400 patients treated successfully.

Celgene in New Jersey focus primarily on treating the source instead of symptom. They specialise in the following;

The stem cell company is also concerned with developing an immune-modulatory agent and therapies for cells and tissues designed to better understand various complexities in diseases.

Continued here:

Stem Cell Companies - A Comprehensive Overview

Posted in Delaware Stem Cells | Comments Off on Stem Cell Companies – A Comprehensive Overview

California Stem Cell Report: California Stem Cell Agency …

Posted: August 23, 2014 at 9:58 am

The California stem cell agency this morning announced that one of its early stage clinical trials has produced encouraging safety data in its search for a therapy that could eradicate AIDS.

Randy Mills, president of the stem cell agency, said,

Calimmune has a powerful scientific pedigree. Nobel Laureate David Baltimore, one of the firms founders, is chairman of the Calimmune board. He also once served on the governing board of the stem cell agency, formally known as the California Institute for Regenerative Medicine (CIRM).

The Calimmune Web site says that the company was formed in 2007 around stem cell technology discovered in the labs of Baltimore, while he was at Caltech, and Irvin Chen at the UCLA AIDS Institute in early 2000. Delaware state records show that the firm was incorporated in 2006.

In addition to Baltimore, another member of the the Calimmune board is Harry George, managing general partner of Solstice Capital, whose Tuscons office shares the same address as Calimmune.

Calimmune and the stem cell agency discussed the therapy at today's session of BIO2014 in San Diego, which is attended by about 15,000 persons in the biotech industry.

Here is a copy of the Calimmune contract with the stem cell agency.

Read more:

California Stem Cell Report: California Stem Cell Agency ...

Posted in Delaware Stem Cells | Comments Off on California Stem Cell Report: California Stem Cell Agency …

Stem Cell Doctors, Physician Team, Our Doctors

Posted: August 23, 2014 at 9:58 am

ALABAMA

ALASKA

ARIZONA ARIZONA STEM CELL TREATMENT CENTER TEAM

Robert M Dryden, M.D., FACS, is Medical Director of the Arizona Stem Cell Treatment Center and Arizona Centre Plastic Surgery. Dr. Dryden completed his undergraduate training at the University of California at Davis, where he was Phi Beta Kappa (U. C. Berkeley chapter) and Phi Kappa Phi Honor Societies after only three years. He then matriculated at the University of California, School of Medicine where he was first in his class, elected to Alpha Omega Alpha Honor Society and a recipient of the prestigious Merck Award. After doing a rotating surgical and medical internship at the University Oregon in Portland, he completed a residency in ophthalmology at the University California in San Francisco. He was the first fellow in the prestigious fellowship in eye and facial plastic surgery under Drs. Crowell Beard and Marvin Quickert at the University of California. He subsequently spent two years at the National Institutes of Health as a member of the United States Public Health Service and consulted and performed cosmetic and reconstructive surgery at the National Naval Medical Center in Bethesda. Dr. Dryden has been practicing and teaching in Tucson and Phoenix, Arizona and at the University of Arizona Medical School since 1971. His practice includes eye and facial reconstructive plastic surgery, general cosmetic surgery, bio-identical hormone replacement and stem cell deployment as the Medical Director of the Arizona Center Stem Cell Treatment Center. Dr. Dryden is board certified in ophthalmology as well as board certified in General Cosmetic Surgery by the American Board of Cosmetic Surgery where he has been both a Trustee and Treasurer. Dr. Dryden was one of the initial founding members of the American Society of Ophthalmic Plastic and Reconstructive surgery and has served as President and Treasurer of the organization. He also served as a President of the American Society of Cosmetic Breast Surgery. He has published over 90 articles in peer-reviewed journals and book chapters in various textbooks. He is a Clinical Professor at the University of Arizona School of Medicine and Mentor of a fellowship in general cosmetic surgery and has taught doctors from around the world. Additionally, he has spoken and taught both nationally and internationally for 40 years. He is a pioneer in the use and development of the latest innovative surgical techniques in eyelid surgery, facial cosmetic surgery, liposuction surgery and breast surgery.

View my CV

PHOENIX STEM CELL TREATMENT CENTER TEAM

Steven M. Gitt, M.D., F.A.C.S. specializes in cosmetic surgery, offering the latest and most innovative techniques in: facial rejuvenation, breast augmentation, laser surgery, liposuction and body contouring and all facets of cosmetic surgery. His patients describe him as caring, compassionate, and understanding and as an excellent listener and communicator. As the founder and medical director of North Valley Plastic Surgery, established in 1993, Dr. Gitt graduated college with distinction from UCLA in 1982 and from medical school with distinction from Wayne State University in 1986. Dr. Gitt was elected to membership in the prestigious Alpha Omega Alpha (AOA) national medical honor society in 1985. Following completion of training in General Surgery at Good Samaritan Hospital in Phoenix, and Plastic Surgery training at the renowned University of Michigan medical center, Dr. Gitt obtained certifications from the American Board of Surgery and the American Board of Plastic Surgery. Dr. Gitt also holds the prestigious Certificate of Advanced Education in Cosmetic Surgery. He was the founder and original medical director of the Comprehensive Wound Healing Center at Paradise Valley Hospital in Phoenix, Arizona. Dr. Gitt is a board certified plastic surgeon. He is a member of the American Society of Plastic Surgeons. Always on the leading edge of technology, Dr. Gitt has offered endoscopic procedures such as brow and face lifting, abdominoplasty, and breast augmentation since 1994, carbon dioxide laser resurfacing since 1995, and Photoderm-Intense Pulsed Light Therapy (IPL) since 1996. He has also accumulated extraordinary experience in Fotofacial and Fotofacial-plusT IPL treatments

View my CV

Ryan B. Tsujimura, M.D. graduated magna cum laude from the University of Washington in Seattle with a B.S. in Biology. He remained in Seattle where he graduated at the top of his class and earned his Medical Degree from the University of Washington School of Medicine. Dr. Tsujimura initiated his postgraduate training at the Oregon Health Sciences University (University of Oregon) in Portland, Oregon where he did his internship in General Surgery. He then moved to Phoenix where he finished his residency in General Surgery. During this time he became Chief Resident of the Burn Unit and then Chief Resident of Surgery in his last year of training. He was given various awards during his training, but the most meaningful was the distinction made by the Chairman of Surgery/Program Director and Mentor: Ive been training surgeons for over a decade, youre the best surgeon Ive been fortunate enough to train. Certified by the American Board of Surgery, Dr. Tsujimura took an Attending Trauma Surgeon at Maricopa County Hospital. This gave him the opportunity to give back to the community and to teach future surgeons. To help influence the surgeons of tomorrow. During this time, he also entered practice and joined the staff of the Scottsdale Healthcare System performing general and vascular operations. Dedicated to patient care, he rapidly became the surgeon to turn to in a time of need. In the continued pursuit to perfect his skills, Dr. Tsujimura took an educational leave from a busy practice to obtain still further training at the Nationally Accredited by the American Board of Plastic Surgery and RRC (Residency Review Committee), Plastic/Reconstructive and Hand Surgery program at the University of Tennessee. While there, he published and lectured on various topics in Aesthetic and Reconstructive Surgery. He also became Administrative Chief Resident. Even during his training in plastic surgery, because of his surgical experience he was frequently called to the operating room by staff surgeons in times of crisis.

View my CV

Read more here:

Stem Cell Doctors, Physician Team, Our Doctors

Posted in Delaware Stem Cells | Comments Off on Stem Cell Doctors, Physician Team, Our Doctors

Stem Cell Treatment for Spinal Cord Injury (SCI) with CT …

Posted: August 23, 2014 at 9:57 am

When injury occurs to the spinal cord, the connections between the brain and the body are hampered or broken, which results in some level of impairment and a certain degree of paralysis. Symptoms may include movement disability, loss of sensation, impaired control of urination and defecation, cramps, pain and depression.

Conventional treatments for spinal cord injury are focused on prevention of secondary damage and providing rehabilitation.

Background information on this condition

With the advancement of stem cell treatments in China now you have a novel treatment option for Spinal Cord Injury. Stem cell therapy can support the natural regeneration processes of the body by stimulating the repair of damaged tissues. It goes beyond symptomatic treatment and may potentially help you to improve or regain some of the impaired functions.

Cell death occurs when cells are injured. However, these dead cells are surrounded by damaged and healthy cells. Stem cells have the potential to stimulate the healing of these injured cells by the secretion of cytokines, such as nerve growth factor to promote the bodys self-repair mechanisms.

Stem cells are injected by an innovative procedure known as a CT-guided intraspinal injection technique and this is supplemented by further stem cell transplantation via lumbar punctures or IV injections.

We are proud to be the pioneers of the CT-guided intraspinal stem cell transplantation surgical procedure, which is a landmark in the field of stem cell therapy for Spinal Cord Injury. To date, CT-guided intraspinal stem cell transplantation is only available at our hospital in China. CT guidance enables the neurosurgeon to target the stem cells precisely, administering the stem cells inside healthy spinal cord tissue adjacent to the lesion. This technique avoids open surgery of the spine. Thus pain, risks, and healing time are all minimized.

Our doctors understand that a variety of factors may influence decisions regarding your treatment. Our team is dedicated to patient education and collaboration so that you are clearly aware of your condition and treatment options. The hospital offers a wide range of treatments and related services. Therefore we advise you to consult with one of our specialists for personalized treatment information before you arrive to China.

We also encourage you to carefully study our CT Guided Transplantation Method and our stem cell treatment schedule.

Continued here:

Stem Cell Treatment for Spinal Cord Injury (SCI) with CT ...

Posted in Connecticut Stem Cells | Comments Off on Stem Cell Treatment for Spinal Cord Injury (SCI) with CT …

UConn-Wesleyan University Stem Cell Core UConn Health

Posted: August 23, 2014 at 9:57 am

University of Connecticut-Wesleyan University Stem Cell Core

Established in 2006, the University of Connecticut (UConn)-Wesleyan University Stem Cell Core is currently located in the Cell and Genome Sciences (CGS) Building, UConn Health at 400 Farmington Avenue, Farmington, Connecticut. Since its establishment, the Core has substantially contributed to the Connecticut stem cell initiative by providing a central source of technologies and materials for research on human embryonic stem cells (hESC) and induced pluripotent stem cells (iPSC).

Initially supported with institutional funds from UConn, and subsequently by the Connecticut State Stem Cell Research Program, we have expanded to incorporate a Genetics and Genomics Division located on the Storrs campus and provide a wide range of services. We have also incorporated a Genome Editing Division by collaborating with the Gene Targeting and Transgenics Facility atUConn Health.

With these crucial services, many UConn researchers have developed novel approaches to addressing fundamental biological questions and tackling deleterious diseases, and produced significant progress. Competitive state stem cell funding has been awarded to many UConn and Wesleyan researchers since 2006.

See the rest here:

UConn-Wesleyan University Stem Cell Core UConn Health

Posted in Connecticut Stem Cells | Comments Off on UConn-Wesleyan University Stem Cell Core UConn Health

Induced Pluripotent Stem Cell Services Induced …

Posted: August 23, 2014 at 9:57 am

Background

The recent discovery of reprogramming human somatic cells into induced pluripotent stem cells (iPS) offers an innovative approach to the study of many human genetic diseases. Like human embryonic stem cells, iPS cells self-renew indefinitely and have unlimited developmental potential. The creation of patient-specific iPS cells holds great promise for understanding genetic disease mechanisms and for in vitro testing of potential therapies. University of Connecticut induced Pluripotent Stem Cell Core (iPSCC) has extensive experiences in deriving iPSCs for many scientists from both academia and industry. We will continue to provide a high quality, reliable, and efficient reprogramming services to the increasing demands at University of Connecticut and elsewhere, both statewide and nationwide.

We currently produce in-house retrovirus for six factors total, four factors, originally developed in Yamanaka lab, including OCT4, SOX2, C-MYC, and KLF4 and two additional factors, NANOG and LIN28, which were used in Thomson lab for reprogramming. In addition, we produce lentivirus using a single polycistronic lentiviral vector (STEMCCA) to improve efficiency and reduce the number of viral integrations. Furthermore, this vector includes the flanking LoxP sites to facilitate Cre-mediated excision of the vector later if necessary Finally, we are in the process of optimizing the integration-free reprogramming protocols such mRNA transduction and episomal approach.

To initiate this service, please contact the iPSCC at ucscicore@uchc.edu and submit using the the sample submission form. We would be happy to answer questions about our iPSCC derivation service. Once arrangements between client and iPSCC are made, the client can submit the sample to us. Clients can submit either frozen or live cultures.

2) Derivation of iPSC Includes:

iPSCC Validation Service: Validation includes, but not limited to, immunocytochemistry, mycoplasma testing, and teratoma service.

We test NANO and SSEA4 immunostaining for one hESC or iPSC line, or 1 to 5 iPSC lines derived from the same fibroblast sample plate as an add-on to the iPSC derivation service. This service may be ordered separately from our iPSC derivation service (e.g., for other cells), if desired.

b. Mycoplasma Testing:

Mycoplasma test. The University of Connecticut iPSCC provides a sensitive and accurate biochemical mycoplasma test using Myco-Alert kit. Clients submit 2 ml of the spent culture medium to be tested. We request to fill out a separate sample submission form before you request the test online.

c. Teratoma Service:

Read the original post:

Induced Pluripotent Stem Cell Services Induced ...

Posted in Connecticut Stem Cells | Comments Off on Induced Pluripotent Stem Cell Services Induced …

Page 2,038«..1020..2,0372,0382,0392,040..2,0502,060..»